Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
DAVID MARCUS: Trump’s base trusts him to play...
Trump weighs striking Iranian nuclear facilities: ‘I may...
GOP says Dems admit ‘guilt’ in Biden health...
Poll position: Where Trump stands in the eyes...
Ilhan Omar claims no one has ‘attacked Americans,’...
‘Squad’ members, GOP lawmaker join forces to reject...
Vance defends Gabbard as ‘critical part’ of Trump...
Trump downplays signs of MAGA unrest over possible...
‘Instincts for restraint’: Senate divided over who gets...
Top Trump ally predicts Senate will blow past...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

Experts sound the alarm over ‘shocking’ study showing significant risks to women who take abortion pills

by admin May 6, 2025
May 6, 2025
Experts sound the alarm over ‘shocking’ study showing significant risks to women who take abortion pills

A new study exposing a significant number of ‘serious adverse events’ occurring among women who have taken mifepristone, also known as the ‘abortion pill,’ has sparked an outcry from the pro-life community, including experts who spoke to Fox News Digital about what the study means for women in the United States. 

‘The biggest thing that will shock most readers of this report is just how different the findings in this study are from what the FDA claims on the abortion drug label,’ Katie Glenn Daniel, SBA Pro Life America director of legal affairs, told Fox News Digital about the recently released study. 

‘What they found is that more than one in ten women will go to the emergency room seeking follow-up care after taking the abortion drugs. The FDA claims that’s more like one in 20 women, which is still concerning, right? If you’ve got a one in twenty chance of something happening, you might take that seriously, but one in 10. It is shocking,’ she continued. ‘This means hundreds of thousands of American women have gone to the hospital for complications from abortions through these abortion drugs and the FDA was not collecting information about those situations. So this study shines a light on what has been happening, what ER doctors certainly know is happening. But what our public health institutions have turned a blind eye to.’

Mifepristone is a ‘pregnancy blocker’ that is used in combination with another medication, misoprostol, to terminate pregnancies, according to Mayo Clinic. It is also used to manage early miscarriages, as it helps prepare the body to empty the uterus.

Research by the Ethics & Public Policy Center in Washington, D.C., has revealed that the rate of serious side effects is 22 times higher than what is indicated on the FDA-approved drug label.

After going through an abortion assisted by mifepristone, nearly 11% of women — more than one in 10 — reported experiencing ‘infection, hemorrhaging, or another serious or life-threatening adverse event,’ according to the study summary.

‘These reports, which analyzed the largest known data set of real-world mifepristone use, confirm what physicians like me and our members are seeing in our clinical practice: that abortion drugs pose significant dangers to women,’ Dr. Christina Francis, a board-certified OB/GYN, told Fox News Digital. 

‘I have had patients face life-threatening hemorrhage, infection, and more after taking these drugs, which are now available to order online without an in-person physician visit to confirm the age of the pregnancy and rule out risk factors. The fact that these data show a serious complication rate that is 22 times higher than what the FDA states reveals the urgent need for further investigation into complications of drug-induced abortions and for policymakers and agencies to reprioritize women’s safety over the interests of the abortion industry. Women and their children deserve better care than these dangerous drugs.’

Mifepristone, which the Biden administration took steps to ensure was made available to women through the mail, is the most well-known abortion pill in the United States, and approximately 63% of all abortions in the U.S. in 2023 were medication abortions, according to the Guttmacher Institute. 

This was an increase from 53% in 2020.

We knew that the Biden administration’s changes to the abortion drug prescribing, which included allowing these drugs to be sent through to mail. We knew that that was harmful for women and girls because there is no medical oversight,’ Daniel told Fox News Digital. ‘You don’t even know if a pregnant woman’s getting these drugs. There have been cases where men order these drugs, to slip them to somebody. The state of Louisiana has a case right now where a mother ordered them and forced her daughter to take them, even though the pregnancy was wanted. So you really lose a lot of the safeguards that are in place when somebody actually physically goes to a doctor’s office.’

Daniel told Fox News Digital she hopes this report will encourage the Trump administration’s FDA to take action to ensure that women and unborn children are protected. 

A drug that puts one in ten women in the hospital is certainly not a drug that is quote unquote good for women or caring for women and I think we need to be realistic about that,’ Daniel said. 

Daniel also explained that the true harm from the pill is likely even worse than the study only includes certain years and only women who used insurance.

‘So there are tons of women, including those who are the most vulnerable, who are left out of this data,’ Daniel pointed out. 

‘There is a lot more to look out here,’ Daniel continued. ‘We see this as the starting point of what the FDA, the CDC, our public health institutions, and our physicians need to be looking at. And we need to have an honest conversation about the fact that 20 years of data shows that these drugs are deadly for children, but they’re also very dangerous for in girls.’

Fox News Digital’s Melissa Rudy contributed to this report

This post appeared first on FOX NEWS

previous post
German conservative’s bid for chancellor falls short, a first in more than 75 years
next post
NASA backs Trump budget blueprint with $6B cut to agency

You may also like

Russian-American ballerina Ksenia Karelina released in prisoner swap...

April 10, 2025

Supreme Court hears pivotal Louisiana election map case...

March 25, 2025

Political betting markets still have plenty of action...

November 29, 2024

Highlights from President-elect Donald Trump’s 1st Inauguration Day;...

January 18, 2025

Defense Department workers no longer required to submit...

May 28, 2025

MIKE POMPEO: Trump’s renewed maximum pressure on Iran...

February 5, 2025

Trump expresses ‘absolute confidence’ as Steve Witkoff is...

May 7, 2025

Trump administration picks’ families have 1 thing in...

November 21, 2024

I was a White House lawyer and I...

February 21, 2025

GOP lawmaker confronted at town hall says protesters’...

March 20, 2025

Recent Posts

  • DAVID MARCUS: Trump’s base trusts him to play strong hand in Iran
  • Trump weighs striking Iranian nuclear facilities: ‘I may do it, I may not do it’
  • GOP says Dems admit ‘guilt’ in Biden health cover-up by boycotting Senate hearing on ‘constitutional scandal’
  • Poll position: Where Trump stands in the eyes of Americans five months into his second presidency
  • Ilhan Omar claims no one has ‘attacked Americans,’ but Iran’s deadly history tells different story

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (792)
    • Investing (2,350)
    • Politics (2,910)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 Sightful Invest. All Rights Reserved.